von Herrath M, Bain SC, Bode B, Clausen JO, Coppieters K, Gaysina L, et al (2021) Anti-interleukin-21 antibody and liraglutide for the preservation of -cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial
Su activacin modula la ingesta y la preferencia por combustibles calricos
Acknowledgements This work was supported by the Nano & Material Technology Development Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (RS-2024-00409405) and the Defense Challengeable Future Technology Program of the Agency for Defense Development, Republic of Korea
Interactions Compounded semaglutide can interact with other medications, including insulin and insulin-releasing medications, which can result in low blood sugar
95% CI: 0.63 - 0.88